Can there be life after death? Biosciences company ReAnima thinks so, and they’ve just been granted permission to find out.
An institutional review board has granted Bioquark, a life sciences company taking part in the ReAnima project, ethical permission to recruit 20 brain-dead patients for a study that will test whether stem cells can bring them back to life.
“We are very excited about the approval of our protocol,” says Bioquark CEO Ira Pastor, a member of the ReAnima advisory board. “With the convergence of the disciplines of regenerative biology, cognitive neuroscience and clinical resuscitation, we are poised to delve into an area of scientific understanding previously inaccessible with existing technologies.”
Stem cells have been used to regenerate heart, pancreatic, eye and brain tissue in clinical studies, and scientists hope that stem cells will also resurrect degenerated neurons.
“It is a long-term vision of ours that a full recovery in such patients is a possibility,” says Pastor, “although that is not the focus of this first study – but it is a bridge to that eventuality.”
In addition to biweekly injections of stem cells, scientists will use continuous peptide injections and laser and nerve stimulation techniques. The study participants will be
To read more, please continue to page 2.